NCT06318234View on ClinicalTrials.gov

PET/MR Evaluation of Regression Grading After Neoadjuvant Therapy for Rectal Cancer

RecruitingOBSERVATIONAL
Enrollment

32

Participants

Timeline

Start Date

January 1, 2024

Primary Completion Date

December 31, 2025

Study Completion Date

December 31, 2025

Conditions
Rectal Cancer
Interventions
DIAGNOSTIC_TEST

18F-FAPI，18F-FDG

FAPI and FDG combined with PET/MR imaging in patients with rectal cancer after neoadjuvant therapy

Trial Locations (1)

Unknown

RECRUITING

Department of Nuclear Medicine, Daping Hospital of Army Medical University, Chongqing

All Listed Sponsors
lead

Xiao Chen

OTHER